Basket Study of Entrectinib (RXDX-101) for the of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Rearrangements (Fusions)

  • Renal Cell Cancer ()
  • Pancreatic Cancer
  • Solid Tumors
  • Skin Cancer
  • Malignant
  • Non Hodgkin ()
  • Lymphoma
  • ()
  • Lung Cancer
  • Non Small Cell Lung Carcinoma
  • Thyroid Cancer
  • Melanoma
  • Head and Neck Cancer
  • Head and Neck Neoplasms